PCL-DOX microdroplets: An evaluation of the enhanced intracellular delivery of doxorubicin in metastatic cancer cells: Via in silico and in vitro approaches

Aman Chandra Kaushik, Ajay Kumar, Chun Yen Yu, Shiao Wei Kuo, Shih Shin Liang, Satya P. Singh, Xiangeng Wang, Yan Jing Wang, Chung Kun Yen, Xiaofeng Dai, Dong Qing Wei, Cheng Tang Pan, Yow Ling Shiue

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Researchers have promoted the use of polymer microspheres in medical engineering and biotechnology, such as embedded drug delivery with polylactic acid microspheres. Polycaprolactone (PCL) is a kind of semi-crystalline polymer, which can be utilized in many varieties of organic solvent. Therefore, PCL has been used as a controlled-release drug carrier for long-term treatment. This study focuses on the fabrication process of biodegradable PCL microcarriers with uniform and controllable particle size (size range is ∼5-100 μm) via an emulsion-solvent evaporation process with ultrasonic micro-droplet atomization technology. Through ultrasonic atomization, micro-droplets of PCL solution were sprayed out directly with highly uniform particle size. The oil micro-droplets of PCL were collected with an aqueous stream in an emulsion process to form a water-oil-water emulsion. The ultrasonic atomizer assisting the emulsification process was adjusted via the stirring equipment to enhance the particle size uniformity. As a result, PCL micro-droplets were sprayed into aqueous solution due to the vertical flow field made by the stirring equipment. The yield rates of PCL microcarriers were improved effectively. Moreover, the cancer pharmaceutical doxorubicin (DOX) was added into the process to obtain drug-loaded microcarriers. The drug-loading efficiency in this process was ∼42.2%, and the encapsulation efficiency of the microcarriers was ∼3.21%. Further, we performed docking and MD simulations of the polycaprolactone-doxorubicin hydrochloride interaction that showed their binding affinity and later validated potential inhibitors. Additionally, we have successfully established the dynamic behavior of an entire biochemical pathway in the presence of polycaprolactone with doxorubicin hydrochloride, using a systems biology approach.

Original languageEnglish
Pages (from-to)12241-12256
Number of pages16
JournalNew Journal of Chemistry
Volume43
Issue number31
DOIs
StatePublished - 1 Jan 2019
Externally publishedYes

ASJC Scopus subject areas

  • Catalysis
  • Chemistry (all)
  • Materials Chemistry

Fingerprint

Dive into the research topics of 'PCL-DOX microdroplets: An evaluation of the enhanced intracellular delivery of doxorubicin in metastatic cancer cells: Via in silico and in vitro approaches'. Together they form a unique fingerprint.

Cite this